Header Logo

Connection

TODD ROSENGART to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications TODD ROSENGART has written about Clinical Trials, Phase II as Topic.
TODD ROSENGART
Connection Strength
0.043
Clinical Trials, Phase II as Topic
  1. Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations. Am Heart J. 2021 11; 241:38-49.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.